Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

December 1, 2004; Volume 45,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Iso, Tatsuya

    1. You have access
      Usefulness of Fasting 18F-FDG PET in Identification of Cardiac Sarcoidosis
      Wataru Okumura, Tsutomu Iwasaki, Takuji Toyama, Tatsuya Iso, Masashi Arai, Noboru Oriuchi, Keigo Endo, Tomoyuki Yokoyama, Tadashi Suzuki and Masahiko Kurabayashi
      Journal of Nuclear Medicine December 1, 2004, 45 (12) 1989-1998;
  2. Israel, Ora

    1. You have access
      Is 18F-FDG PET/CT Useful for Imaging and Management of Patients with Suspected Occult Recurrence of Cancer?
      Ora Israel, Maya Mor, Luda Guralnik, Nirit Hermoni, Diana Gaitini, Rachel Bar-Shalom, Zohar Keidar and Ron Epelbaum
      Journal of Nuclear Medicine December 1, 2004, 45 (12) 2045-2051;
  3. Itti, Emmanuel

    1. You have access
      Assessment of Myocardial Reperfusion After Myocardial Infarction Using Automatic 3-Dimensional Quantification and Template Matching
      Emmanuel Itti, Gregory Klein, Jean Rosso, Eva Evangelista, Jean-Luc Monin, Pascal Gueret, Michel Meignan and Jean-Philippe Thirion
      Journal of Nuclear Medicine December 1, 2004, 45 (12) 1981-1988;
  4. Iwasaki, Tsutomu

    1. You have access
      Usefulness of Fasting 18F-FDG PET in Identification of Cardiac Sarcoidosis
      Wataru Okumura, Tsutomu Iwasaki, Takuji Toyama, Tatsuya Iso, Masashi Arai, Noboru Oriuchi, Keigo Endo, Tomoyuki Yokoyama, Tadashi Suzuki and Masahiko Kurabayashi
      Journal of Nuclear Medicine December 1, 2004, 45 (12) 1989-1998;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 45 (12)
Journal of Nuclear Medicine
Vol. 45, Issue 12
December 1, 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire